Google News
spot_img

GAVIS

Lupin buys GAVIS Pharma for further development

Drug major Lupin declared the completion of acquisition of the US-based GAVIS Pharmaceuticals LLC and Novel Laboratories (GAVIS). This venture will scale up the company's status in US generic market and will also have a control on high-value and...
- Advertisement -

Latest News

The Luxottica report card for 2022

A look at how the world’s largest eyewear company fared in terms of revenue growth in key regions across...
- Advertisement -

Login to your account below

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.